25 April 2024 - Biosimilar price will be about 85% lower than Humira.

In an important step toward driving long-term affordability and access to treatments for chronic and complex conditions, Evernorth Health Services announced that it will have a Humira biosimilar available for $0 out of pocket for eligible patients of its specialty pharmacy Accredo beginning this June. The high- and low-concentration interchangeable biosimilar will be produced for Evernorth's affiliate private label pharmaceutical distributor, Quallent Pharmaceuticals, through agreements with multiple manufacturers. It will be available at $0 out of pocket for most patients through Quallent's copay assistance program. This program is estimated to save individual patients around $3,500 on average per year.

Read Evernorth Health Services press release